Healthcare provider profile · identity verified

Andrean A Gurov, MD

Internal Medicine · MEDFORD, OR · NPI 1972551703

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	675	187
Levothyroxine Sodium	Levothyroxine Sodium	446	114
Lisinopril	Lisinopril	381	111
Amlodipine Besylate	Amlodipine Besylate	347	111
Losartan Potassium	Losartan Potassium	289	93
Gabapentin	Gabapentin	279	78
Omeprazole	Omeprazole	275	75
Furosemide	Furosemide	272	67
Trazodone Hcl	Trazodone Hcl	264	59
Metoprolol Succinate	Metoprolol Succinate	260	64
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	253	46
Potassium Chloride	Potassium Chloride	252	61
Metformin Hcl	Metformin Hcl	211	63
Hydrochlorothiazide	Hydrochlorothiazide	204	60
Simvastatin	Simvastatin	172	50
Tamsulosin Hcl	Tamsulosin Hcl	157	51
Rosuvastatin Calcium	Rosuvastatin Calcium	144	45
Alprazolam	Alprazolam	135	29
Albuterol Sulfate Hfa	Albuterol Sulfate	132	58
Atenolol	Atenolol	125	33
Zolpidem Tartrate	Zolpidem Tartrate	119	30
Duloxetine Hcl	Duloxetine Hcl	118	29
Pantoprazole Sodium	Pantoprazole Sodium	118	34
Clopidogrel	Clopidogrel Bisulfate	115	28
Allopurinol	Allopurinol	112	28
Pravastatin Sodium	Pravastatin Sodium	111	26
Metoprolol Tartrate	Metoprolol Tartrate	110	31
Carvedilol	Carvedilol	107	31
Tizanidine Hcl	Tizanidine Hcl	102	24
Lorazepam	Lorazepam	97	20
Sertraline Hcl	Sertraline Hcl	93	18
Escitalopram Oxalate	Escitalopram Oxalate	91	18
Eliquis	Apixaban	82	23
Tramadol Hcl	Tramadol Hcl	79	19
Meloxicam	Meloxicam	77	27
Quetiapine Fumarate	Quetiapine Fumarate	77	12
Fluticasone Propionate	Fluticasone Propionate	75	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	75	21
Buspirone Hcl	Buspirone Hcl	74	23
Hydralazine Hcl	Hydralazine Hcl	70	16
Jardiance	Empagliflozin	70	23
Metformin Hcl Er	Metformin Hcl	67	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	67	13
Trulicity	Dulaglutide	65	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	20
Spironolactone	Spironolactone	62	21
Alendronate Sodium	Alendronate Sodium	60	21
Glipizide	Glipizide	59	18
Oxycodone Hcl	Oxycodone Hcl	59	16
Ondansetron Odt	Ondansetron	58	20
Citalopram Hbr	Citalopram Hydrobromide	55	17
Estradiol	Estradiol	53	14
Donepezil Hcl	Donepezil Hcl	50	13
Warfarin Sodium	Warfarin Sodium	48	suppressed
Prednisone	Prednisone	47	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	46	14
Famotidine	Famotidine	44	14
Propranolol Hcl	Propranolol Hcl	43	11
Meclizine Hcl	Meclizine Hcl	39	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	39	27
Glipizide Er	Glipizide	36	11
Montelukast Sodium	Montelukast Sodium	36	suppressed
Ozempic	Semaglutide	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Novolog Flexpen	Insulin Aspart	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Clonazepam	Clonazepam	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Finasteride	Finasteride	31	suppressed
Ibuprofen	Ibuprofen	31	15
Promethazine Hcl	Promethazine Hcl	31	suppressed
Nitroglycerin	Nitroglycerin	30	19
Lamotrigine	Lamotrigine	29	suppressed
Varenicline Tartrate	Varenicline Tartrate	28	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Nystatin	Nystatin	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Diazepam	Diazepam	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Carbamazepine Er	Carbamazepine	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	11
Celecoxib	Celecoxib	22	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Valsartan	Valsartan	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Bupropion Hcl	Bupropion Hcl	20	suppressed
Cephalexin	Cephalexin	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Creon	Lipase/Protease/Amylase	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Naproxen	Naproxen	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Digoxin	Digoxin	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Carbidopa-Levodopa Er	Carbidopa/Levodopa	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Phenobarbital	Phenobarbital	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Felodipine Er	Felodipine	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nyamyc	Nystatin	12	suppressed
Progesterone	Progesterone, Micronized	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Temazepam	Temazepam	12	suppressed
Topiramate	Topiramate	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Ramipril	Ramipril	11	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error